pioglitazone has been researched along with fluorodeoxyglucose f18 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboulkassim, T; Aliaga, A; Hamel, E; Nicolakakis, N; Rosa-Neto, P; Tong, XK | 1 |
| Calcagno, C; Dickson, SD; Fayad, ZA; Fisher, EA; Fuster, V; Hayashi, K; Lin, J; Moon, MJ; Moshier, E; Mounessa, JS; Nicolay, K; Roytman, M; Rudd, JH; Tsimikas, S; Vucic, E | 1 |
| Harada, H; Hayabuchi, N; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mawatari, K; Mizoguchi, M; Nitta, Y; Oba, T; Tahara, A; Tahara, N; Yamagishi, S; Yasukawa, H | 1 |
| Finn, AV; Tawakol, A | 1 |
| Marwick, TH; Narula, J | 1 |
| Bockisch, A; Nagarajah, J; Rosenbaum-Krumme, SJ | 1 |
| Abe, T; Fukumoto, Y; Honda, A; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mizoguchi, M; Narula, J; Nitta, Y; Tahara, A; Tahara, N; Yamagishi, S | 1 |
| Chen, WJ; de Roos, A; Diamant, M; Greulich, S; Lamb, HJ; Lammertsma, AA; Lubberink, M; Ouwens, DM; Rijzewijk, LJ; Romijn, JA; Ruige, JB; Smit, JW; van der Meer, RW | 1 |
| Hayabuchi, N; Honda, A; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mizoguchi, M; Nitta, Y; Tahara, A; Tahara, N; Yamagishi, S | 1 |
| Cheong, SJ; Jeong, HJ; Kim, EM; Lee, CM; Lim, ST; Sohn, MH | 1 |
| Lv, SZ; Wang, ZM; Yan, YF; Zhang, MD; Zhang, YH; Zhao, QM; Zhao, XC | 1 |
| Ayer, A; Cariou, B; Charpentier, F; Dollet, L; Jagu, B; Joubert, M; Le May, C; Magré, J; Manrique, A; Marechal, X; Montaigne, D; Prieur, X; Staels, B; Tesse, A; Toumaniantz, G | 1 |
| Feng, T; Li, J; Nie, M; Xu, J; Xu, Z; Yan, Y; Zhang, M; Zhao, Q; Zhao, X | 1 |
| Cendes, F; Cintra, RM; de-Lima-Júnior, JC; Folli, F; Monfort-Pires, M; Rachid, B; Ramos, CD; Rodovalho, S; Van de Sande-Lee, S; Velloso, LA | 1 |
5 trial(s) available for pioglitazone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
Topics: Aged; Anti-Inflammatory Agents; Aortic Diseases; Aortography; Biomarkers; Blood Glucose; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Japan; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
Topics: Administration, Oral; Aged; Body Fat Distribution; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Intra-Abdominal Fat; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Subcutaneous Fat; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2013 |
Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes.
Topics: Activins; Adipose Tissue; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Double-Blind Method; Fluorodeoxyglucose F18; Glucose; Heart; Heart Ventricles; Humans; Hypoglycemic Agents; Inhibin-beta Subunits; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Myocardium; Myocytes, Cardiac; Organ Size; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome; Ventricular Remodeling | 2013 |
Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Topics: Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fluorodeoxyglucose F18; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Effect of pioglitazone treatment on brown adipose tissue volume and activity and hypothalamic gliosis in patients with type 2 diabetes mellitus: a proof-of-concept study.
Topics: Adipose Tissue, Brown; Adult; Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Gliosis; Humans; Hypothalamus; Male; Middle Aged; Obesity; Organ Size; Overweight; Pioglitazone; Positron Emission Tomography Computed Tomography; Proof of Concept Study; Thiazolidinediones | 2019 |
9 other study(ies) available for pioglitazone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.
Topics: Aging; Animals; Antioxidants; Blotting, Western; Cerebrovascular Circulation; Cerebrovascular Disorders; Cognition; Fibrosis; Fluorodeoxyglucose F18; Hypoglycemic Agents; Immunohistochemistry; Laser-Doppler Flowmetry; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Cerebral Artery; Muscle, Smooth, Vascular; Parasympathetic Nervous System; Pioglitazone; Radiopharmaceuticals; Thiazolidinediones; Transforming Growth Factor beta1; Vibrissae | 2011 |
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortography; Atherosclerosis; Biomarkers; Contrast Media; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Immunohistochemistry; Inflammation; Lipids; Macrophages; Magnetic Resonance Angiography; Multimodal Imaging; Neovascularization, Pathologic; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed | 2011 |
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Aortography; Atherosclerosis; Carotid Artery Diseases; Contrast Media; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Magnetic Resonance Angiography; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2011 |
Imaging of pharmacologic intervention decoding therapeutic mechanism or defining effectiveness?
Topics: Anti-Inflammatory Agents; Aortic Diseases; Aortography; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2011 |
Pioglitazone therapy in progressive differentiated thyroid carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Thiazolidinediones; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Topics: Anilides; Animals; Biological Transport; Cell Line, Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Inflammation; Macrophages; Mice; Neoplasms; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Thiazolidinediones; Tissue Distribution | 2015 |
Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography.
Topics: Animals; Biomarkers; Blood Glucose; C-Reactive Protein; Fluorodeoxyglucose F18; Hypoglycemic Agents; Inflammation; Lipids; Male; Matrix Metalloproteinase 9; Pioglitazone; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Thiazolidinediones; Thrombosis; Tomography, X-Ray Computed | 2015 |
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Echocardiography; Fluorodeoxyglucose F18; Glucosides; GTP-Binding Protein gamma Subunits; Heart; Heterotrimeric GTP-Binding Proteins; Hyperglycemia; Hypoglycemic Agents; Lipodystrophy; Magnetic Resonance Imaging; Mice; Mice, Knockout; Myocardium; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Ventricular Dysfunction, Left; Ventricular Function | 2017 |
Effect of pioglitazone on inflammation and calcification in atherosclerotic rabbits : An
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Hypoglycemic Agents; Inflammation; Male; Pioglitazone; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Random Allocation; Tomography, X-Ray Computed | 2018 |